Wednesday, January 10, 2018

US FDA News: Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall - Product Mislabeling

Missed doses of Clopidogrel increases the risk of heart attack and stroke which can be life threatening.
Read more: Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall - Product Mislabeling